Trials / Unknown
UnknownNCT03145051
Efficacy of Nasal Irrigation With Respimer® Netiflow® vs Saline Among Patients With Cystic Fibrosis and Chronic Rhinosinusitis
Prospective, Randomized, Cross-over, Multicenter, Trial Comparing the Efficacy and Tolerability of Nasal Irrigation With Respimer® Netiflow® Mineral Salts Solution Versus Saline Among Patients With Cystic Fibrosis and Suffering From Chronic Rhinosinusitis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Laboratoire de la Mer · Industry
- Sex
- All
- Age
- 11 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, randomized, cross-over, multicenter, trial comparing the efficacy and tolerability of nasal irrigation with Respimer® mineral salts solution versus saline solution both administered with Respimer® Netiflow® medical device among patients aged ≥ 11 years and older with cystic fibrosis and suffering from chronic rhinosinusitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Saline solution | a nasal irrigation care |
| OTHER | Respimer Netiflow | a nasal irrigation care |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-10-01
- Completion
- 2017-12-01
- First posted
- 2017-05-09
- Last updated
- 2017-09-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03145051. Inclusion in this directory is not an endorsement.